Navigation Links
Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
Date:1/12/2009

30 total patients will be treated.

New Alliance for Use of Quadra-Fuse, Multi-pronged Injection Needles

Jennerex also announced today an alliance with Rex Medical, a manufacturer of advanced multi-pronged needles, for the targeted intratumoral administration of JX-594. Jennerex shall exclusively use Rex Medical Quadra-Fuse needles ("QF Needles") for intratumoral injections of JX-594 in clinical development, and Rex Medical shall work collaboratively with Jennerex to effectively apply this technology to JX-594 clinical development.

"We are excited to be collaborating with Rex Medical, the market leader in this field, for application of Quadra-Fuse needle technology with JX-594. This is the first needle designed for optimizing therapeutic delivery of fluids/agents into target tissue zones. This innovative multi-pronged design allows us to precisely target distribution of JX-594 for optimal therapeutic effect. The result is an innovative and potentially landmark combination of a highly targeted biotherapeutic agent with a sophisticated medical device for targeted delivery," stated Dr. Kirn.

About JX-594

JX-594 is a cancer biotherapeutic product, currently in Phase 2 trials, from a proprietary breakthrough class of targeted and armed oncolytic poxviruses. Tumor destruction and safety was shown in patients with diverse cancer types on three Phase 1 trials; treated patients were end-stage and had no effective therapies available. JX-594 multiplies selectively within cancer cells, leading to their destruction. These newly created copies of JX-594 are then released and are able to infect and eradicate other tumor cells both locally and in distant sites in the body. This cycle of JX-594 replication, cancer cell destruction, release and spread is then repeated. Normal cells are not affected by JX-594 resulting in safety and tolerability. The poxvirus strain backbone of JX-594 has
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
2. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
3. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
4. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
5. New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
6. New Data Shows Veramyst Effectively Treats Symptoms of Perennial Allergic Rhinitis
7. New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
10. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
11. Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...tCall/--Pharmasset,Inc.(Nasdaq: VRUS )announcedtod...SWX:ROG.VX;RO.S,OTCQX:RHHBY),willcontinuefortherem...rialofRG7128,afirst-in-classnucleosideanalogpolyme...us(HCV)infection.Thedecisionwasreachedafteraschedu...C)ofallavailablesafetydatafromthefirstcohortofappr...
(Date:11/23/2009)...irstCall/--Oceanside Pharmaceuticals ,partofValean...nnouncedthatithasnowlaunchedchlordiazepoxidehydroc...versionofLibrax®.Oceansidehasreceiveditsfirst...#174;genericmarket. ,, "Valeant,sOceansideunith...ssuccessfullaunchanddistributionof5%fluorouracil,V...
(Date:11/23/2009)...ancedSterilizationProducts(ASP),aleadingglobalinfe...cquisitionbyitsFrenchaffiliate,ApsisS.A.S.,ofGlost...ectionprocessesandtechnologiestopreventhealthcare-...closed. ,, GlosterEuropedesignsandmarketsaninno...infectionofpatientenvironmentssuchashospitalandope...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2Grant received for eye disorder research 50639 1Grant received for eye disorder research 50639 2FDA Approves Multaq 28R 29 for Patients with Atrial Fibrillation or Atrial Flutter 50636 1FDA Approves Multaq 28R 29 for Patients with Atrial Fibrillation or Atrial Flutter 50636 2FDA Approves Multaq 28R 29 for Patients with Atrial Fibrillation or Atrial Flutter 50636 3FDA Approves Multaq 28R 29 for Patients with Atrial Fibrillation or Atrial Flutter 50636 4FDA Approves Multaq 28R 29 for Patients with Atrial Fibrillation or Atrial Flutter 50636 5FDA Approves Multaq 28R 29 for Patients with Atrial Fibrillation or Atrial Flutter 50636 6FDA Approves Multaq 28R 29 for Patients with Atrial Fibrillation or Atrial Flutter 50636 7Lixte Biotechnology Holdings Lead Compound LB 1 2 Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models 12880 1Lixte Biotechnology Holdings Lead Compound LB 1 2 Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models 12880 2Lixte Biotechnology Holdings Lead Compound LB 1 2 Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models 12880 3
...t. 9 The Wellion Linus Blood Glucose,Monitoring S...curacy,testing, recently received certification by...ic Research TNO ("TNO"). TNO is an independent gro...cts medical devices. The,Wellion Linus Blood Gluco...O approval is a testament to the quality and accur...
...tential for Correcting Devastating Genetic Disease...,a mouse brain well connected to other areas, rese...o the entire brain -- after one injection of,gene ...ed in people,researchers may have a potential meth...vastating congenital human neurological disorders,...
Other Medicine Technology:WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests 2One Shot of Gene Therapy Spreads Through Brain in Animal Study 2One Shot of Gene Therapy Spreads Through Brain in Animal Study 3
(Date:11/23/2009)...--JustintimefortheThanksgivingcelebration, turkey...cookingupadeliciousmeal:deep-friedturkeyin100%pean...urkeyfrying.net alsoprovidesrecipesfromtheleadi...ingtheturkeybeyondThanksgiving.Thenewlylaunchedsit...ngwith100%peanutoil. ,, "Ienjoyfryingwithpeanut...
(Date:11/23/2009)... mental and physical health , , MONDAY, ...take as many years off your life as smoking does, ...of depression and anxiety appears to be better for...came to their conclusions after analyzing death re...ing the four years after the survey, the death rat...
(Date:11/23/2009)...iddle age are more than twice as likely to develop... from the Sahlgrenska Academy. , The study has j...ology . , "Anyone carrying a lot of fat around t...due to a heart attack or stroke," says Deborah Gus.... "If they nevertheless manage to live beyond 70, ...
(Date:11/23/2009)...ild-up of a brain peptide called amyloid-beta. Tha... of almost all drug research pursuing a cure for t...t that may be counterproductive, says Dr. Inna Slu...logy and Pharmacology, Sackler Faculty of Medicine...ta is also necessary to maintain proper brain func...
(Date:11/23/2009)...tCall/--InstacareCorp.(OTCBulletinBoard:ISCR)annou...t=,_blank,title=, MD@Hand ,> MD@Hand ,target=,_bl...d ,> MD@Hand ,> MD@Hand ,target=,_blank,title=, M...d ,target=,_blank,title=, MD@Hand ,> MD@Hand ,tar..., MD@Hand ,> MD@Hand ,> MD@Hand ,target=,_blank,t...
Breaking Medicine News(10 mins):Health News:Depression May Up Death Risk to That of Smoking 2Health News:Upending textbook science on Alzheimer's disease 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 3Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 4Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 6Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 7
... new research from British Columbia found that abo... their non-Aboriginal counterparts to use methado...ction. Dr. Evan Wood and colleagues evaluate...Aboriginal participants used methadone, compared w...
...eople going abroad who suffer from food allergies ... a wordlist of more than 200 ingredients , from nu...n translated into 30 languages. The list, ...kagings, say the compilers, from Wageningen Univer...
...housands of young girls are skipping insulin jabs ...f blindness, heart disease and even death. ...men with the disease miss the life- saving injecti...ften develops in childhood or adolescence, need da...
...he Society for the Protection of the Rights of the...at cases of child abuse are on the rise in Pakista...lly abused in the country everyday. Jahanz... people have failed to protect their children and ...
...n what they call a "stunning research advance," in...r have been able to use non-toxic chemical injecti...e bodies of laboratory animals. They say the disco...y. Investigators say these findings may als...
...oston Scientific Corporation announced the launch ...(SCS) System, the world's smallest rechargeable S...onic pain of the trunk, back and limbs. Precision ...e control and charger to simplify control of patie...
Other Medicine News:Health News:Diabetic Skip Jabs to Stay Slim 2Health News:Scientists Discover Key to Manipulating Fat 2Health News:New Spinal Cord Stimulation System Launched 2
...th factor binding protein-2 (IGFBP-2) is one of si...roposed) which specifically bind and modulate the ...of IGFBP-2 for IGF-II is estimated to be significa...in regulation of IGF-II action. Studies in the fet...
...ric proteins that suppress the secretion of FSH (f...nhibin consists of two distinct chains, or subunit...sists of the alpha-subunit and betaA-subunit. Inhi...nit. Only the dimeric forms of the molecule, conta...
...tor II (IGF-II) is a 7.5 kDa peptide which is secr...ave mitogenic and metabolic actions involved in ce...by binding to target cell receptors. IGF-II binds ...monomeric protein which also serves as the recepto...
...asma protein A (PAPP-A) is a large placenta-derive...centrations by placental trophoblast cells, and is...ing concentrations throughout gestation until deli...e measurable levels have been found in non-pregnan...
Medicine Products: